Triumeq is a prescription medication used to treat HIV-1 infection in adults and pediatric patients weighing at least 40 kg. It is a fixed-dose combination of three antiretroviral drugs: abacavir, dolutegravir, and lamivudine. These drugs work together to help control the HIV virus and improve the immune system’s ability to fight off infections.

Abacavir is a nucleoside reverse transcriptase inhibitor, dolutegravir is an integrase inhibitor, and lamivudine is another nucleoside reverse transcriptase inhibitor. By combining these three drugs into one pill, Triumeq simplifies the treatment regimen for patients with HIV-1 infection.

It is important to take Triumeq exactly as prescribed by your healthcare provider. Missing doses or not taking the medication as directed can lead to the development of drug-resistant strains of HIV. It is also important to inform your healthcare provider of any other medications or supplements you are taking, as they may interact with Triumeq.

Common side effects of Triumeq may include headache, diarrhea, nausea, and fatigue. These side effects are usually mild and go away on their own. However, if you experience any severe or persistent side effects, it is important to contact your healthcare provider.

Overall, Triumeq is an effective and convenient treatment option for individuals living with HIV-1 infection. It is important to work closely with your healthcare provider to monitor your progress and make any necessary adjustments to your treatment plan. With proper adherence to medication and regular medical care, individuals with HIV-1 infection can lead healthy and fulfilling lives.